Mathieu, Alice
Reignier, Jean
Le Gouge, Amélie
Plantefeve, Gaetan
Mira, Jean-Paul
Argaud, Laurent
Asfar, Pierre
Badie, Julio
Botoc, Nicolae-Vlad
Bui, Hoang-Nam
Chatellier, Delphine
Chauvelot, Louis
Cracco, Christophe
Darmon, Michael
Delbove, Agathe
Devaquet, Jérôme
Dumont, Louis-Marie
Gontier, Olivier
Groyer, Samuel
Hourmant, Yannick
Jaber, Samir
Lambiotte, Fabien
Madeux, Benjamin
Maizel, Julien
Martinet, Olivier
Maxime, Virginie
Mercier, Emmanuelle
Nay, Mai-Anh
Nseir, Saad
Piton, Gael
Quenot, Jean-Pierre
Renault, Anne
Rigaud, Jean-Philippe
Schneider, Francis
Sirodot, Michel
Souweine, Bertrand
Tamion, Fabienne
Thévenin, Didier
Thieulot-Rolin, Nathalie
Tinturier, Francois
Tirot, Patrice
Vinatier, Isabelle
Vinsonneau, Christophe
Lascarrou, Jean-Baptiste
Laurent, Alexandra
,
,
Article History
Received: 13 March 2024
Accepted: 14 June 2024
First Online: 12 July 2024
Declarations
:
: RESIREA was a planned study conducted in parallel with the randomised controlled multicentre NUTRIREA-3 trial, which was approved by the competent ethics committee (<i>Comité de Protection des Personnes Sud-Méditerranée 2</i>, #2018-A00424-51). The RESIREA study protocol was approved by the ethics committee of the French Intensive Care Society (CE SRLF 18–19). Specific informed consent for inclusion in the RESIREA study was obtained from the patients, or from their next of kin in patients unable to consent.
: Not applicable.
: The authors declare that they have no competing interests related to this article.